Questions? Call an MS-certified nurse now
1-800-887-8100
Shauna F., on Copaxone (glatiramer acetate injection) for RRMS

Starting COPAXONE®
(glatiramer acetate injection)

COPAXONE® (glatiramer acetate injection): My trust. My confidence. My therapy.

In the evolving landscape of relapsing-remitting multiple sclerosis (RRMS) therapies, you can feel reassured that COPAXONE® has demonstrated benefits and the kind of track record that has been built through clinical experience and proven results.

These benefits may help to explain why many in the RRMS community have put their trust in COPAXONE®.

  • COPAXONE® is effective for early treatment1,2
  • COPAXONE® has been proven to reduce relapses in RRMS1,3,4
  • COPAXONE® has been shown to have an impact on MRI measures1,2,5
  • COPAXONE® has a demonstrated safety profile with 3 years of clinical experience1
  • COPAXONE® is well tolerated1
  • COPAXONE® has been approved for RRMS since 19961

You can get started and stay committed to COPAXONE® by learning about the support, services and resources that Shared Solutions® provide.

Shared Solutions® is your support every step of the way

Even though you may just be starting your journey, we have experience assisting thousands of people who have been touched by relapsing-remitting multiple sclerosis (RRMS).

Your Case Manager has it covered

Once you take the next positive step toward therapy and enroll with Shared Solutions®, a Case Manager will be assigned to you. From financial resources, to in-home injection training, 24/7 nurse support, or simply lending an ear, Shared Solutions® provides access to everything you need to help you start—and successfully stay—on treatment. When your Case Manager calls, you can expect to talk about:

Insurance FinancialInsurance and benefits investigation
Fast and affordable access to COPAXONE®Injection TrainingIn-home injection/refresher training
Free in-home training with a nurse and customized materials to help with your daily injections Home Delivery.pngHome delivery
Delivery of COPAXONE® refills right to your door (if you qualify) Peer SupportOne-on-one support from RRMS peers
Talk to someone who knows what it’s like to live with RRMS Clinical nurse educatorsClinical Nurse Educators
Clinical nurse educators provide personal training and support

Call Shared Solutions® at 1-800-887-8100 to get started. We’re here for you Monday through Friday, from 8:00 AM to 8:00 PM (CT). For urgent needs, our MS-certified nurses are available 24/7.



COP-40055
copaxone co-pay solutions

Your co-pay could
be no more than

$35 per month†

Learn More
 

New!

COPAXONE
iTracker™

Your mobile tool for tracking injections

Learn More
 
more solutions planner

Managing

your injectable therapy from your desktop.

Set Up Your Planner
 
 
COP-40015

COPAXONE® (glatiramer acetate injection) is indicated for the reduction of the frequency of relapses in relapsing-remitting multiple sclerosis, including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.


IMPORTANT SAFETY INFORMATION ABOUT COPAXONE®

The most common side effects of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These reactions are usually mild and seldom require professional treatment. Be sure to tell your doctor about any side effects.

Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems.

A permanent indentation under the skin at the injection site may occur, due to a local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

After you inject COPAXONE®, call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, severe pain at the injection site or other uncomfortable changes in your general health. Do not give yourself any more injections until your doctor tells you to begin again.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

 
 
 
 
  1. COPAXONE® (glatiramer acetate injection) prescribing information. Teva Neuroscience, Inc.
  2. Comi G, Martinelli V, Rodegher M, et al; for the PreCISe study group. Lancet. 2009;374(9700):1503-1511.
  3. Bornstein MB, Miller A, Slagle S, et al. N Engl J Med. 1987;317(7):408-414.
  4. Johnson KP, Brooks BR, Cohen JA, et al. Neurology. 1995;45(7):1268-1276.
  5. Comi G, Filippi M, Wolinsky JS. Ann Neurol. 2001;49(3):290-297.

†Certain limits and restrictions apply.
Terms and Conditions: COPAXONE Co-pay Solutions™ is open to both new and existing patients who are residents of the US or Puerto Rico and who have private insurance coverage. The offer is not valid for patients covered in whole or in part by Medicaid, Medicare, TRICARE, or any other federal or state government pharmaceutical assistance plan or program (regardless of whether a specific prescription is covered), or by private health benefit programs that reimburse for the entire cost of prescription drugs. Use of this offer must be consistent with the terms of any drug benefit provided by a health insurer, health plan, or private third-party payor. This offer is void where prohibited by law, taxed, or restricted. No additional purchase is required. This offer is valid only at participating pharmacies and may be changed or discontinued at any time without notice. This program is not health insurance.

COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered trademark of Teva Neuroscience, Inc.

autoject®2 for glass syringe is a registered trademark of Owen Mumford, Ltd. COPAXONE CO-PAY SOLUTIONS™ is a trademark of Teva Pharmaceutical Industries Ltd. © 2013 Teva Neuroscience, Inc. All Rights Reserved. This site is intended for US residents only.

COPAXONE iTracker™ is a trademark of Teva Pharmaceutical Industries Ltd.
Apple, iTunes, and iPhone are trademarks of Apple, Inc., registered in the U.S. and other countries.

COP-40092